To investigate FOXA1’s role in NPC progression and chemosensitivity, we utilized the hTFtarget database to identify FOXA1-target genes, focusing on BMI1, known for its association with cisplatin resistance in NPC [26]. The gene discussed is FOXA1; the disease is nasopharyngeal carcinoma.